DEPTULA-HICKS DARLENE M
Insider CIK 1089409 · ALDX Director · TTOO SVP & Chief Financial Officer · XBIO Director · FSTX Treasurer and CFO · PIRS Sr. Vice President and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 84,557 | — | $0 | 84,557 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 9,756 | — | $0 | 9,756 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 59,823 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 24,902 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 25,894 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 28,426 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | U Tender | 2023-03-08 | 2023-03-09 | 30,898 | $7.12 | $220.0K | 25,539 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer | 2023-03-08 | 2023-03-09 | 25,539 | $7.12 | $181.8K | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 24,902 | — | $0 | 24,902 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2022-01-09 | 2022-01-11 | 59,823 | — | $0 | 59,823 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 25,894 | — | $0 | 54,320 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-02 | 30,000 | — | $0 | 56,437 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award | 2020-11-20 | 2021-08-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2020-11-20 | 2020-11-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2020-11-20 | 2020-11-24 | 28,426 | — | $0 | 28,426 | SEC↗ |
| TTOO T2 Biosystems, Inc. | P Buy | 2017-06-06 | 2017-06-08 | 4,000 | $3.58 | $14.3K | 4,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2017-06-15 | 10,000 | — | $0 | 20,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2017-06-15 | 10,000 | — | $0 | 30,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2017-06-15 | 10,000 | — | $0 | 40,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2016-12-23 | 10,000 | — | $0 | 31,416 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2016-12-23 | 10,000 | — | $0 | 41,416 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2016-12-23 | 10,000 | — | $0 | 51,416 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2016-12-20 | 2016-12-23 | 10,000 | — | $0 | 61,416 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2016-06-13 | 2016-06-15 | 5,000 | $1.66 | $8.3K | 5,000 | SEC↗ |
| TTOO T2 Biosystems, Inc. | A Award deriv | 2016-05-01 | 2017-05-02 | 175,000 | — | $0 | 175,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2015-09-01 | 2015-09-03 | 450,000 | — | $0 | 450,000 | SEC↗ |